Rates of Gender-Affirming Surgery Examined in Cisgender Males, Gender-Diverse
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 10, 2024 -- For adults and minors, most breast reductions performed on cisgender males and transgender and gender-diverse (TGD) people are performed on cisgender males, according to a research letter published online June 27 in JAMA Network Open.
Dannie Dai, from the Harvard T.H. Chan School of Public Health in Boston, and colleagues characterized the relative use of gender-affirming surgeries by TGD and cisgender populations. TGD people who received a gender-affirming procedure were identified; the rate of people who received a gender-affirming procedure with a TGD-related diagnosis per 100,000 total people was calculated for adults or minors. The proportion of breast reductions used by cisgender males without a TGD-related diagnosis and TGD people was compared.
In 2019, 47,437,919 adults who were insured and 22,827,194 minors (16.8, 11.9, and 71.3 percent ages 15 to 17, 13 to 14, and 12 years or younger, respectively) who were insured were included in the sample. The researchers found that the rate of undergoing a gender-affirming surgery with a TGD-related diagnosis was 5.3 per 100,000 total adults compared with 2.1, 0.1, and 0 per 100,000 minors aged 15 to 17, 13 to 14, and 12 years or younger, respectively. Overall, 59.7 and 96.4 percent of gender-affirming surgical procedures identified among adults and minors were chest-related procedures. Eighty percent of the 636 breast reductions among cisgender male and TGD adults were performed on cisgender males; 97 percent of the 151 breast reductions among cisgender male minors and TGD male minors were performed on cisgender male minors.
"These findings suggest that concerns around high rates of gender-affirming surgery use, specifically among TGD minors, may be unwarranted," the authors write. "Low use by TGD people likely reflects adherence to stringent standards of gender-affirming care."
One author disclosed ties to industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Endolymphatic Sac Decompression Effective for Vertigo, Migraine
WEDNESDAY, May 28, 2025 -- For Meniere disease (MD) patients with migraine, endolymphatic sac decompression (ELSD) is effective, providing postoperative relief of vertigo and...
One-Week Radiotherapy for Breast Cancer Safe, Effective Up to 10 Years
TUESDAY, May 27, 2025 -- A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule for patients with invasive...
Pediatric Magnet Ingestion Rates Still High
THURSDAY, May 22, 2025 -- Global pediatric magnet ingestion rates remain high and incidence has increased, despite the implementation of national policies, according to a review...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.